Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Corporate Integrity Agreements
Johnson and Johnson 2013 Settlement and Corporate Integrity Agreement
On November 4, 2013, the Department of Justice (DOJ) announced that Johnson & Johnson (J&J) and its pharmaceutical…
Companies Add Recoupment of Executives Bonuses to Compliance Cases
In two recent settlements involving off-label promotion and corporate integrity agreements (CIA) with HHS-OIG, new provisions were…
HHS OIG: Listing of Pharmaceutical and Device Corporate Integrity…
Below is a list in alphabetic order of the major pharmaceutical and medical device manufacturer corporate integrity agreements…
Amgen Settlement and Corporate Integrity Agreement
Adding to the long list of pharmaceutical settlements involving off-label promotion, Amgen Inc., the world’s largest biotechnology…
Boehringer Ingelheim Settlement and Corporate Integrity Agreement
While it has been a few months since the last large settlement involving the off-label promotion of pharmaceutical products, the…
CME Grant Disclosure 2011 and 1st ½ of 2102
We have compiled a chart of companies that disclose their educational grant payments for 2011 and 2012. Once the final Physician…
Senate Finance Committee Open Letter Seeks Input to Fight Fraud
The Senate Finance Committee recently posted an open letter on its website to the health care sector soliciting industry…
Abbott Settlement and Corporate Integrity Agreement
Continuing the recent trend of large legal settlements with pharmaceutical companies, the Department of Justice (DOJ) this week…